Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment
Simon Birk Kjær Jensen(University of Copenhagen), Signe S. Torekov(University of Copenhagen), J. Lundgren(University of Copenhagen), Tummas Ternhamar(University of Copenhagen), Victor Sørensen(University of Copenhagen), Christian R. Juhl(University of Copenhagen), Jens‐Erik Beck Jensen(Hvidovre Hospital), Sten Madsbad(Hvidovre Hospital), Bente Stallknecht(University of Copenhagen), Niklas Rye Jørgensen(Glostrup Hospital), Jens J. Holst(University of Copenhagen), Eva Winning Lehmann(University of Copenhagen), Charlotte Janus(University of Copenhagen), Rasmus Michael Sandsdal(University of Copenhagen)
Cited by 109
Related Papers
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
Low Physical Activity Accentuates the Effect of the <i>FTO</i> rs9939609 Polymorphism on Body Fat Accumulation
|Diabetes|2007|476
Impact of postprandial glycaemia on health and prevention of disease
|Obesity Reviews|2012|470
Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined
|New England Journal of Medicine|2021|469
Incretins, insulin secretion and Type 2 diabetes mellitus
|Diabetologia|2004|438